Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome?
S Ryan, C T Taylor, W T McNicholas
https://pubmed.ncbi.nlm.nih.gov/19561283/Actively Recruiting
Led by National University of Malaysia · Updated on 2026-07-14
50
Participants Needed
1
Research Sites
4 weeks
Total Duration
Obstructive sleep apnea OSA is a widespread health concern characterized by underdiagnosis, especially among adults. Obesity is a major risk factor for developing OSA, and its rising prevalence globally and in Malaysia contributes significantly to this problem. OSA can lead to serious cardiovascular and neurocognitive effects, including hypertension, insulin resistance, heart failure, poor concentration, memory loss, and increased risk of accidents. This study is a randomized crossover trial comparing two types of CPAP devices the conventional AirSense 10 and the portable AirMini. Participants with moderate to severe OSA will use each device for 7 days in random order. The study aims to assess user satisfaction, air leak, comfort, portability, maintenance, and treatment efficacy measured by reductions in apnea-hypopnea index AHI and required pressure levels. Participants will undergo a sleep study to confirm their OSA diagnosis and then be randomized to start with either CPAP device. After each 7-day usage period, they will complete questionnaires rating their experience with the devices. Data on device effectiveness and user satisfaction will be collected and analyzed. The total participation time involves two consecutive 7-day treatment periods with assessments at the end of each period.
CONDITIONS
Comparative Assessment of Sleep Positive Airway Pressure Modalities (CASPAM)
M
Mohamed Faisal Abdul Hamid, MBBS(IIUM)
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
National University of Malaysia
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 7 days
Participants use either the AirSense 10 or AirMini CPAP machine for 7 days and complete a satisfaction questionnaire at the end.
1 visit to complete questionnaire after 7 days
Duration - 7 days
Participants switch to the other CPAP device for 7 days and complete the same satisfaction questionnaire at the end.
1 visit to complete questionnaire after 7 days
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
S Ryan, C T Taylor, W T McNicholas
https://pubmed.ncbi.nlm.nih.gov/19561283/Brian W Rotenberg, Claudio Vicini, Edward B Pang...
https://pubmed.ncbi.nlm.nih.gov/27048606/Anna Abbasi, Sushilkumar Satish Gupta, Nitin Sabharwal...
https://pubmed.ncbi.nlm.nih.gov/34381578/National University of Malaysia
Lead Sponsor